1Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
3Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741
4The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112
5Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852
7Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med, 2002,347:1 825
8Madrid AH,Escobar C,Rebollo JM,et al.Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation:results of the irbesartan-amiodarone trial.Card Electrophysiol Rev 2003 ;7(3):243-246.
9Madrid AH,Bueno MG,Rebollo JM,et al.Use of irbesartan to maintain sinus rhythm in patients with long lasting persistent atrial fibrillation:a prospective and randomized study.Circulation 2002; 106(3):331-336.
